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Do preeclampsia symptoms resolve after intrauterine death 
of a fetus?
Preeklampsi semptomları fetal ölüm sonrası kaybolur mu?
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Case Report / Olgu Sunumu
Serdar Balcı1, Taylan Bodur2, Yusuf Aytaç Tohma1, Recep Emre Okyay3, Bahadır Saatli3, 
Sabahattin Altunyurt3
İkiz eşinin ölümünden sonra preeklamptik semptomların devam ettiği iki olguyu sunuyoruz. 
Olgu 1: Otuz yedi yaşında, nullipar, 26 hafta ikiz gebelik kan basıncı yüksekliği, ödem ve bir fetüste gelişme geriliği nedeniyle kliniğimize refere edildi. 
Üç hafta sonra geri kalan fetüs öldü. Takip eden üç haftada, ultrason ölçümlerinde yaşayan fetüsün gelişiminde yavaşlama ve umblikal arterde ters akım 
saptandı. Otuz dördüncü haftanın sonunda sezaryen gerçekleştirildi ve sağlıklı kız bebek doğurtuldu. 
Olgu 2: Otuz üç yaşında, nullipar, 27 hafta ikiz gebelik kan basıncı yüksekliği ve bir fetüste gelişme geriliği nedeniyle kliniğimize refere edildi. Otuz birinci 
gebelik haftasında geri kalan fetüs öldü. Takip eden 2 haftada, ultrason ölçümlerinde yaşayan fetüsün gelişiminde yavaşlama ve umblikal arterde ters akım 
saptandı. Otuz üçüncü haftanın sonunda sezaryen gerçekleştirildi ve sağlıklı kız bebek doğurtuldu.
Bu olgulardaki ilginç nokta yaşayan ikiz eşlerindeki ikincil etkilerdi. İkiz eşinin ölümünden sonraki periyotta yaşayan fetüste gelişmede yavaşlama, ters 
umblikal akım ve annede kan basıncında artış ve proteinüri görüldü. Biz bu belirtilerin preeklampsinin geç başlangıçlı sistemik etkilerinin (sistemik 
maternal endotelyal aktivasyon ve/veya sistemik maternak enflamatuvar yanıt gibi) bir kanıtı olduğunu düşünmekteyiz.
Anahtar Kelimeler: Preeklampsi, ikiz gebelik, gelişme geriliği
Abstract
We present two cases of twin pregnancies without resolution of preeclamptic symptoms after intrauterine death of one twin. 
Case 1: A nulliparous woman aged 37 years was referred at 26 weeks of gestation because of arterial hypertension, edema, and growth restriction in one 
twin. Three weeks later the restricted twin died. During the following three weeks, ultrasound examinations showed a reduced growth velocity of the 
surviving fetus and reversed umbilical flow. At the end of the 34th week of gestation, cesarean section was performed and a healthy female infant was 
delivered.
Case 2: A nulliparous woman aged 33 years with a 27-week twin pregnancy was referred because of arterial hypertension and discordant growth. The 
restricted twin died at 31 weeks of gestation. Following the death, within two weeks the growth of the co-twin started to slow down and reversed end 
diastolic flow presented. At the end of the 33rd week of gestation, cesarean section was performed and a healthy female infant was delivered. 
The interesting point of these cases was the secondary effects on the co-twins. During the time after intrauterine deaths of one twin, the surviving fetuses 
started to show a reduced growth velocity and reversed umbilical flow and mothers had increased blood pressure and proteinuria again. We think that 
both cases are evidence of late on-set systemic maternal effects (such as systemic maternal endothelial activation and/or systemic maternal inflammatory 
response) depends on preeclampsia.
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Introduction
Preeclampsia originates from the placenta, and its progressive 
clinical course is only treated by delivery of the placenta(1). The 
incidence of disease is 3-5% and it is known as a major cause of 
maternal and perinatal mortality(2). Although the etiology and 
pathogenesis remain to be clarified, termination of pregnancy 
or delivery of the placenta eradicates the disease; therefore, 
the placenta is undoubtedly related to preeclampsia(3). Twin 
gestations occur in 3.2% of pregnancies and are associated 
with increased risks of gestational diabetes mellitus, preterm 
delivery, intrauterine growth restriction, hypertension and 
hemorrahage(4). Additionally, the risk of preeclampsia in twin 
pregnancies increases more than twice compared with singleton 
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pregnancies(4). We present two cases of twin pregnancies 
without resolution of preeclamptic symptoms after the 
intrauterine death of one twin.
Case Reports
Case 1
A nulliparous woman aged 37 years was referred at 26 weeks of 
gestation because of arterial hypertension, edema, and growth 
restriction in one twin. On admission her blood pressure 
was 160/100 mmHg. In our centre, ultrasound examination 
confirmed growth restriction (weight estimation: 389 g) and 
reversed umbilical flow with cerebral redistribution in one 
twin, with a normal co-twin (estimated weight: 855 g). This 
was a dichorionic, diamniotic twin pregnancy. The quantitative 
analysis of proteinuria in a 24-hour urine sample taken after 
admission showed 2.708 g/day. To avoid prematurity, expectant 
management was planned. The patient received alpha-
methyldopa in a dosage of 1000 mg daily for blood pressure 
control and magnesium sulfate at a daily dosage of 1500 mg 
to prevent convulsions. Two days later, because of intolerable 
nausea and vomiting, we had to stop the magnesium sulfate 
but we kept going on alpha-methyldopa. During the following 
three weeks, the blood pressure was under partial control, 
ultrasound examinations showed no evidence of growth of the 
restricted twin and confirmed severe doppler abnormalities; the 
co-twin’s assessment was reassuring. Some days later restricted 
twin died but doppler flows of the surviving twin were normal. 
Accordingly, we decided to prolong the pregnancy under close 
observation. Significant proteinuria occured again at 31 weeks 
of gestation, accompanied by a rise in blood pressure. During 
the following three weeks, ultrasound examinations showed 
a reduced growth velocity of the surviving fetus and reversed 
umbilical flow. At the end of the 34th week of gestation, cesarean 
section was performed and a healthy female infant weighing 
1670 g was delivered, followed by a macerated female fetus 
of nearly 200 g. The mother recoverd quickly and her blood 
pressure was normal on the third day postpartum.
Case 2
A nulliparous woman aged 33 years with a 27-week twin 
pregnancy was referred because of arterial hypertension 
and discordant growth. On admission her blood pressure 
was 170/105 mmHg. Our ultrasound check showed growth 
restriction (weight estimation: 698 g) and reversed umbilical 
flow in one twin, with a normal co-twin (estimated weight: 
1.060 g). The examination also revealed a dichorionic, 
diamniotic twin pregnancy. In a 24-hour urine sample 
showed proteinuria (4.850 g/day). Expectant management 
was planned to prevent prematurity. The patient received 
alpha-methyldopa in a daily dosage of 1000 mg for blood 
pressure control and magnesium sulfate at a dosage of 1500 
mg daily to prevent convulsions. During the following two 
weeks, beside the partial blood pressure control, ultrasound 
examinations revealed no growth in the restricted twin and 
abnormal umblical artery flow; the co-twin’s assessment was 
good. At 31 weeks of gestation, the restricted twin died and 
a significant proteinuria (6.650 g/day) reappeared but the co-
twins doppler flows were normal. Following the death, growth 
of co-twin started to draw back within two weeks and reversed 
end diastolic flow presented. At the end of the 33rd week of 
gestation, cesarean section was performed and a healthy 
female infant weighing 1.370 g was delivered, followed by a 
macerated female fetus of almost 800 g. We discharged the 
mother from hospital after her blood pressure normalized on 
the fourth day postpartum.
Discussion
It is certain that the placenta takes a central role in the 
pathogenesis of preeclampsia. The importance of poor 
placentation as a feature of the disorder is well documented(5). 
However, we still do not know the reasons of poor placentation. 
In these cases there are two separate placentas. One of them is 
preeclamptic, the pathologic report documented low weights 
with fibrin and thrombosis inside the vessels, and the others 
were normal. We still do not know why one of the twin placentas 
has abnormal development when both have the same maternal 
factors such as immunity or blood pressure. One explanation is 
local factors such as fetus or placental localization, which could 
possibly affect placental growth. 
Another interesting point of these cases was the secondary 
effects on the co-twins. After intrauterine deaths of one twin, the 
surviving fetuses started to show a reduced growth velocity and 
reversed umblical flow and the mothers had increased blood 
pressure and proteinuria again. We think that this is evidence of 
late on-set systemic maternal effects such as systemic maternal 
endothelial activation and/or systemic maternal inflammatory 
response) depends on preeclampsia. 
Usually preeclampsia progresses without any recovery until 
birth. Few cases of resolution of preeclampsia after spontaneous 
intrauterine death of one twin or selective termination of a 
dichorionic pregnancy have been reported(1,6,7). Narasimhulu 
et al.(8) reported resolution of superimposed preeclampsia in a 
surviving fetus after the intrauterine demise of its co-twin and 
suggested that placental involution after fetal demise was the 
key to resolution of preeclampsia (resolution period take 1 to 3 
weeks). However, according to our cases, even if the fetus dies, 
preeclampsia could not be curable unless placental seperation 
occurred. The greatest disparity of our cases compared with 
those in the literature was the amount of proteinuria, nearly 
5 g/day in 24-hour urine sample. Consequently, severe 
preeclampsia may differ from mild preeclampsia, without 
any resolution or resolution in longer time (more than 3 
weeks). In addition, a retrospective analysis of outcomes 
in pregnant women who had expectant managemant with 
severe preeclampsia at less than 27 weeks’ gestation revealed 
that overall perinatal survival was 57% (9% of them were 
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multifetal gestations)(9). As a result, resolution of preeclampsia 
in dichorionic twin pregnancies following intrauterine death 
of restricted fetus is still uncertain, especially in severe 
preeclampsia. 
To our knowledge, these are the first cases to describe the return 
of preeclamptic symptoms in twins after the intrauterine death 
of one twin in the literature. Further studies are needed for the 
comprehension of preeclampsia and recognition of placental 
factors responsible for the persistence of the disease.
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